StockWatch
·
Pharmaceuticals
Corporate Action30 Sept 2026, 02:54 pm

Aarey Drugs Allots 11.5 Lakh Equity Shares on Warrant Conversion

AI Summary

Aarey Drugs & Pharmaceuticals Ltd announced the allotment of 11,50,000 Equity Shares of face value Rs. 10/- each, pursuant to the conversion of Fully Convertible Equity Share Warrants. The conversion was approved by the Board of Directors on September 30, 2026, upon receipt of Rs. 47.85 per warrant. This allotment, part of a preferential issue at an offer price of Rs. 63.80 per warrant, aggregates to Rs. 5,50,27,500/-. The company's issued and paid-up capital has increased accordingly. Prior to this, 23,70,000 warrants were converted on August 6, 2026. A total of 14,80,000 warrants remain outstanding for conversion within 18 months from the allotment date of May 23, 2025.

Key Highlights

  • 11,50,000 equity shares allotted upon warrant conversion.
  • Total value of conversion is Rs. 5,50,27,500/-.
  • Warrants were issued on a preferential allotment basis.
  • Capital structure adjusted post-allotment.
  • 14,80,000 warrants are still outstanding.